RCA
BPTH

Rowland Carmichael Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

Rowland Carmichael Advisors’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-110
Closed -$8K – 346
2018
Q4 		$8K Hold
110
– – ﹤0.01% 286
2018
Q3 		$26K Hold
110
– – 0.01% 316
2018
Q2 		$66K Hold
110
– – 0.03% 306
2018
Q1 		$88K Hold
110
– – 0.05% 265
2017
Q4 		$89K Hold
110
– – 0.05% 273
2017
Q3 		$159K Hold
110
– – 0.09% 238
2017
Q2 		$171K Hold
110
– – 0.1% 229
2017
Q1 		$365K Hold
110
– – 0.22% 135
2016
Q4 		$596K Hold
110
– – 0.35% 89
2016
Q3 		$618K Hold
110
– – 0.39% 85
2016
Q2 		$878K Hold
110
– – 0.55% 64
2016
Q1 		$1.14M Buy
+110
New +$712K 1.06% 22

Other funds holding BPTH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rowland Carmichael Advisors's BPTH Position: Q1 2019 in Review

Rowland Carmichael Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q1 2019, closing a stake of 110 shares — an estimated $8K sold.

Rowland Carmichael Advisors first reported a position in BPTH in Q1 2016 and held it in 12 quarters. The position peaked at $1.14M in Q1 2016. 18 funds tracked by Wall St. Rank hold BPTH as of Q1 2019.

  • Rowland Carmichael Advisors reported no remaining Bio-Path Holdings Inc position as of Q1 2019 after selling out during the quarter.
  • Rowland Carmichael Advisors sold 110 Bio-Path Holdings Inc shares in Q1 2019, an estimated $8K.
  • Rowland Carmichael Advisors first reported a position in Bio-Path Holdings Inc in Q1 2016 and held it in 12 quarters.
  • Rowland Carmichael Advisors's Bio-Path Holdings Inc position peaked at $1.14M in Q1 2016.
  • 18 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2019.

Based on Rowland Carmichael Advisors's 13F filing for Q1 2019, filed 10 Feb 2020.